Vitro Biopharma, Inc. Quarterly Operating Lease, Liability, Current in USD from Q3 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Vitro Biopharma, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q3 2022 to Q4 2024.
  • Vitro Biopharma, Inc. Operating Lease, Liability, Current for the quarter ending January 31, 2025 was $117K, a 8.26% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $117K -$10.5K -8.26% Jan 31, 2025 10-Q 2025-03-20
Q3 2024 $119K -$10.7K -8.19% Oct 31, 2024 10-Q 2025-03-20
Q2 2024 $122K -$3.72K -2.96% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $125K +$77.3K +163% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $127K +$78.7K +161% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $130K +$80.1K +160% Oct 31, 2023 10-K 2025-01-28
Q2 2023 $126K Jul 31, 2023 10-Q 2023-08-28
Q1 2023 $47.5K Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $48.8K Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $50.1K Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.